| From visual exploration to storytelling and back again S Gratzl, A Lex, N Gehlenborg, N Cosgrove, M Streit Computer Graphics Forum 35 (3), 491-500, 2016 | 137 | 2016 |
| Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets D Varešlija, N Priedigkeit, A Fagan, S Purcell, N Cosgrove, PJ O’Halloran, ... JNCI: Journal of the National Cancer Institute 111 (4), 388-398, 2019 | 135 | 2019 |
| The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export J Vohhodina, EM Barros, AL Savage, FG Liberante, L Manti, P Bankhead, ... Nucleic acids research 45 (22), 12816-12833, 2017 | 116 | 2017 |
| Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities N Cosgrove, D Varešlija, S Keelan, A Elangovan, JM Atkinson, ... Nature communications 13 (1), 514, 2022 | 77 | 2022 |
| Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer AL Browne, S Charmsaz, D Varešlija, A Fagan, N Cosgrove, S Cocchiglia, ... Oncogene 37 (15), 2008-2021, 2018 | 37 | 2018 |
| A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis L Zhu, D Retana, P García‐Gómez, L Álvaro‐Espinosa, N Priego, ... EMBO molecular medicine 14 (3), e14552, 2022 | 32 | 2022 |
| Epigenome-wide SRC-1–mediated gene silencing represses cellular differentiation in advanced breast Cancer E Ward, D Varešlija, S Charmsaz, A Fagan, AL Browne, N Cosgrove, ... Clinical Cancer Research 24 (15), 3692-3703, 2018 | 24 | 2018 |
| Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic … D Varešlija, E Ward, SP Purcell, NS Cosgrove, S Cocchiglia, ... Oncogene 40 (7), 1318-1331, 2021 | 22 | 2021 |
| Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease GP Dowling, S Keelan, NS Cosgrove, GR Daly, K Giblin, S Toomey, ... Breast Cancer Research and Treatment 207 (3), 471-476, 2024 | 20 | 2024 |
| An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer P Borde, N Cosgrove, S Charmsaz, ST Safrany, L Young Cancer gene therapy 30 (2), 368-374, 2023 | 19 | 2023 |
| ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis S Charmsaz, B Doherty, S Cocchiglia, D Varešlija, A Marino, N Cosgrove, ... BMC medicine 18 (1), 349, 2020 | 17 | 2020 |
| Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer S Keelan, M Ola, S Charmsaz, S Cocchiglia, D Ottaviani, S Hickey, ... Cancer Communications 43 (5), 615, 2023 | 10 | 2023 |
| Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer N Cosgrove, AJ Eustace, P O’Donovan, SF Madden, B Moran, J Crown, ... NPJ Breast Cancer 9 (1), 72, 2023 | 3 | 2023 |
| Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples N Cosgrove, OM Fitzpatrick, L Grogan, BT Hennessy, SJ Furney, ... Frontiers in Oncology 14, 1483126, 2025 | 2 | 2025 |
| Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma L Flanagan, A Coughlan, N Cosgrove, A Roe, Y Wang, S Gilmore, ... Haematologica 109 (9), 2930, 2024 | 2 | 2024 |
| Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer D Ottaviani, M Ola, A Allotta, Y Maati Chaibi, S Hickey, P Jagust, ... JNCI: Journal of the National Cancer Institute, djaf295, 2025 | 1 | 2025 |
| Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases NS Cosgrove, D Vareslija, S Keelan, S Furney, JM Carter, SN Hart, ... CANCER RESEARCH 81 (4), 2021 | 1 | 2021 |
| Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis S Charmsaz, B Doherty, S Cocchiglia, D Varešlija, A Marino, N Cosgrove, ... BMC medicine 23 (1), 682, 2025 | | 2025 |
| 21P Implications of KMT2C knockdown for DNA damage repair in breast cancer P Bredin, S Toomey, E Tinsley, G Dowling, N Cosgrove, S Furney, ... Annals of Oncology 34, S193, 2023 | | 2023 |
| Cover Image, Volume 43, Issue 5 S Keelan, M Ola, S Charmsaz, S Cocchiglia, D Ottaviani, S Hickey, ... Cancer Communications 43 (5), i, 2023 | | 2023 |
